Elaiophylin reduces body weight and lowers glucose levels in obese mice by activating AMPK

Obesity is an epidemic affecting 13% of the global population and increasing the risk of many chronic diseases. However, only several drugs are licensed for pharmacological intervention for the treatment of obesity. As a master regulator of metabolism, the therapeutic potential of AMPK is widely rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Ruoxuan, Meng, Yongmei, Zhang, Haibo, Yang, Chen, Li, Wei, Zhang, Cheng, Zhang, Jinye, Sun, Renqiang, Li, Zengxia, Jiang, Wei, Zhang, Chensong, Zhang, Changsheng, Yuan, Hai-Xin, Dang, Yongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528873/
https://www.ncbi.nlm.nih.gov/pubmed/34671010
http://dx.doi.org/10.1038/s41419-021-04264-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528873/
https://www.ncbi.nlm.nih.gov/pubmed/34671010
http://dx.doi.org/10.1038/s41419-021-04264-9

Ejemplares similares